PWPS
MYGN icon

Pinnacle Wealth Planning Services’s Myriad Genetics MYGN Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-604
Closed -$2.72K – 2807
2026
Q1 		$2.72K Sell
604
-6,916
-92% -$36K ﹤0.01% 2392
2025
Q4 		$46.2K Buy
+7,520
New +$54.5K ﹤0.01% 1247
2021
Q1 		– Sell
-106
Closed -$2K – 1359
2020
Q4 		$2K Buy
+106
New +$1.71K ﹤0.01% 1952

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pinnacle Wealth Planning Services's MYGN Position: Q2 2026 in Review

Pinnacle Wealth Planning Services sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 604 shares — an estimated $2.72K sold.

Pinnacle Wealth Planning Services first reported a position in MYGN in Q4 2020 and held it in 3 quarters. The position peaked at $46.2K in Q4 2025. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Pinnacle Wealth Planning Services reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
  • Pinnacle Wealth Planning Services sold 604 Myriad Genetics shares in Q2 2026, an estimated $2.72K.
  • Pinnacle Wealth Planning Services first reported a position in Myriad Genetics in Q4 2020 and held it in 3 quarters.
  • Pinnacle Wealth Planning Services's Myriad Genetics position peaked at $46.2K in Q4 2025.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.